Suchergebnisse - "Krabbe, L-M"

PubPharm (16)

1

Corrigendum to "Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer : Results of an International Consortium" [Eur Urol Focus 2021;7:1347-54

enthalten in: European urology focus | 2022

von Mir, M. | Marchioni, M. | Zargar, H. | +33

ErratumFor: Eur Urol Focus. 2021 Nov;7(6):1347-1354. - PMID 32771446

2

Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer : Results of an International Consortium

enthalten in: European urology focus | 2021

von Mir, M. | Marchioni, M. | Zargar, H. | +33

ErratumIn: Eur Urol Focus. 2022 Feb 15;:. - PMID 35181282

3

Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy

enthalten in: World journal of urology | 2019

von Vasdev, N. | Zargar, H. | Noël, J. | +38

4

Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy

enthalten in: World journal of urology | 2018

von Vasdev, N. | Zargar, H. | Noël, J. | +38

5

Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy

enthalten in: World journal of urology | 2018

von Vasdev, N. | Zargar, H. | Noël, J. | +38

6

Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy

enthalten in: World journal of urology | 2018

von Vasdev, N. | Zargar, H. | Noël, J. | +38

7

Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma : results of an international multi-institutional study on 2189 patients

enthalten in: World journal of urology | 2017

von Borgmann, H. | Musquera, M. | Haferkamp, A. | +27

CommentIn: World J Urol. 2018 Aug;36(8):1335-1336. - PMID 29256019

8

Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients

enthalten in: World journal of urology | 2017

von Borgmann, H. | Musquera, M. | Haferkamp, A. | +27

9

Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients

enthalten in: World journal of urology | 2017

von Borgmann, H. | Musquera, M. | Haferkamp, A. | +27

10

Prognostic significance of Fuhrman grade and age for cancer-specific and overall survival in patients with papillary renal cell carcinoma: results of an international multi-institutional study on 2189 patients

enthalten in: World journal of urology | 2017

von Borgmann, H. | Musquera, M. | Haferkamp, A. | +27